Kamni Sharma Haase
Student
-
Det medisinske fakultet

Publikasjoner
-
Solli, Kristin Klemmetsby; Kunøe, Nikolaj; Latif, Zill-E-Huma; Haase, Kamni Sharma; Opheim, Arild & Krajci, Peter [Vis alle 9 forfattere av denne artikkelen] (2019). Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: Extension of a randomized clinical trial. European Addiction Research. ISSN 1022-6877. 25(6), s. 1–7. doi: 10.1159/000501931. Fulltekst i vitenarkiv
-
Latif, Zill-E-Huma; Solli, Kristin Klemmetsby; Opheim, Arild; Kunøe, Nikolaj; Saltyte Benth, Jurate & Krajci, Peter [Vis alle 8 forfattere av denne artikkelen] (2019). No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study. American Journal on Addictions. ISSN 1055-0496. 38(2), s. 77–85. doi: 10.1111/ajad.12859.
-
Latif, Zill-E-Huma; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Opheim, Arild; Kunøe, Nikolaj & Krajci, Peter [Vis alle 8 forfattere av denne artikkelen] (2018). Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone A Randomized Clinical Trial and Follow-up Study. JAMA psychiatry. ISSN 2168-6238. doi: 10.1001/jamapsychiatry.2018.3537. Fulltekst i vitenarkiv
-
Solli, Kristin Klemmetsby; Latif, Zill-E-Huma; Opheim, Arild; Krajci, Peter; Haase, Kamni Sharma & Saltyte Benth, Jurate [Vis alle 8 forfattere av denne artikkelen] (2018). Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a nine-month follow-up to a three-month randomized trial. Addiction. ISSN 0965-2140. 113(10), s. 1840–1849. doi: 10.1111/add.14278.
-
Tanum, Lars; Solli, Kristin Klemmetsby; Latif, Zill-E-Huma; Saltyte Benth, Jurate; Opheim, Arild & Haase, Kamni Sharma [Vis alle 8 forfattere av denne artikkelen] (2017). Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence. A Randomized Clinical Noninferiority Trial. JAMA psychiatry. ISSN 2168-6238. 74(12), s. 1197–1205. doi: 10.1001/jamapsychiatry.2017.3206.
-
Haase, Kamni Sharma; Kunøe, Nikolaj; Opheim, Arild; Gaulen, Zhanna; Njå, Anne-Lill Mjølhus & Zill E, Huma Latif [Vis alle 8 forfattere av denne artikkelen] (2016). Interest in extended release naltrexone among opioid users. European Addiction Research. ISSN 1022-6877. 22(6), s. 301–305. doi: 10.1159/000447964.
-
Kunøe, Nikolaj; Opheim, Arild; Solli, Kristin Klemmetsby; Gaulen, Zhanna; Haase, Kamni Sharma & Zill E, Huma Latif [Vis alle 7 forfattere av denne artikkelen] (2016). Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX). BMC Pharmacology & Toxicology. ISSN 2050-6511. 17(1). doi: 10.1186/s40360-016-0061-1.
Publisert 31. okt. 2012 11:53
- Sist endret 11. aug. 2016 11:50